Orapred ODT
NDC 59212-701, prednisolone sodium phosphate, tablet, orally disintegrating, from Advanz Pharma (US) Corp..
- Product NDC
- 59212-701
- Status
- Listed
- Labeler
- Advanz Pharma (US) Corp.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021959
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59212-701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PREDNISOLONE SODIUM PHOSPHATE15 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59212-701-12 | 59212070112 | 2 BLISTER PACK in 1 CARTON (59212-701-12) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (59212-701-06) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1e379543-c4cf-4e72-953b-db15b7f0c2a1
Use it
Look up 59212-701 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59212-701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59212-701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.